Epigenetic Mechanisms Underlying the Dynamic Expression of Cancer-Testis Genes, PAGE2, -2B and SPANX-B, during Mesenchymal-to-Epithelial Transition

S Yilmaz-Ozcan, A Sade, B Kucukkaraduman… - PloS one, 2014 - journals.plos.org
Cancer-testis (CT) genes are expressed in various cancers but not in normal tissues other
than in cells of the germline. Although DNA demethylation of promoter-proximal CpGs of CT …

[HTML][HTML] A stemness and EMT based gene expression signature identifies phenotypic plasticity and is a predictive but not prognostic biomarker for breast cancer

MW Akbar, M Isbilen, N Belder, SD Canli… - Journal of …, 2020 - ncbi.nlm.nih.gov
Aims: Molecular heterogeneity of breast cancer results in variation in morphology, metastatic
potential and response to therapy. We previously showed that breast cancer cell line sub …

Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer

YW Wang, YL Tuan, JY Wang… - Oncology …, 2025 - spandidos-publications.com
Amplification of human epidermal growth factor 2 receptor (HER2) and overexpression of
estrogen receptor (ER) and/or progesterone receptor (PR) are key determinants in the …

[PDF][PDF] Uygulamaya Yönelik Genetik Bilimci Gözü İle Kanserde Gelecek Öngörüleri

AO Güre, S Demirkol, MW Akbar, AG Akçay - researchgate.net
520% 50'ye yakın azalma ile ilişkili olduğu net olarak ortaya çıkmaktadır. Ancak akciğer
kanseri ve akciğerle ilgili diğer patolojiler için, tütün kullanımının bırakılmasından sonra …

Characterization of chemosensitivity profiles of breast cancer cell lınes, with and without stem cell like features

MW Akbar - 2014 - search.proquest.com
Breast cancer is the second most common cause of death worldwide from cancer due to
complications with its diagnosis and resistance to therapy. Recent studies have shown that …

[引用][C] The main prognostic and predictive biomarker in solid tumors is a reversible epithelial to mesenchymal transition (EMT)

S Demirko, AO Gure - COST Action CM1407, 5 th MC/WG Meeting